Cardiology Update

APRIL 25, 2024

RELIEVE-HF investigators evaluated the efficacy and safety of the V-wave interatrial shunt system in patients with heart failure. The primary endpoint was a composite of all-cause mortality, left ventricular assist device (LVAD)/heart transplantation, HF hospitalizations, worsening HF, and KCCQ score changes. April 6, 2024.

Heart Failure 98

Heart Failure Heart Transplant Transplant Research 98

Cardiology Update

JANUARY 2, 2024

As we step into 2024, the field of cardiology continues to offer exciting opportunities for knowledge exchange and networking at in-person conferences. Here is a preview of the upcoming cardiology conferences planned for 2024. Fees: Visit the ESC ACVC 2024 website for registration options. Hashtag: #ACVC2024 2.

Heart Failure 111

Heart Failure Atherosclerosis Cardiovascular Imaging Non-Invasive Cardiology 111

Cardiology Update

SEPTEMBER 24, 2024

Chadi Alraies discusses some of the important trials presented at the European Society of Cardiology 2024 congress. Read more about the important ESC 2024 highlights. The post ESC 2024 Highlights appeared first on Cardiology Update.

Research 130

Research Heart Failure Interventional Cardiology General Cardiology 130

DAIC

APRIL 30, 2024

Getty Images milla1cf Tue, 04/30/2024 - 12:56 April 30, 2024 — A multicenter study led by Vanderbilt University Medical Center ( VUMC ) and Lipscomb University College of Pharmacy in Nashville has identified a potential new treatment for acute heart failure , a leading cause of hospitalization and death.

Heart Failure 105

Heart Failure Hospital Research COVID-19 105

DAIC

MAY 2, 2024

Getty Images milla1cf Thu, 05/02/2024 - 10:17 May 2, 2024 — Reprieve Cardiovascular, Inc. Reprieve’), a development stage company focused on pioneering an intelligent approach to acute decompensated heart failure (ADHF) treatment, today highlighted the publication of TREAT-AHF study results in JACC: Heart Failure.

Heart Failure 105

Heart Failure Inpatient Hospital Research 105

DAIC

JULY 30, 2024

This study by Fujita Health University researchers revealed that kidney function, considered in terms of estimated glomerular filtration rate (eGFR), can be used as a predictor for SCD in patients with congestive heart failure. During the follow-up period, 198 of these patients suffered from SCD.

Sudden Cardiac Death 111

Sudden Cardiac Death Heart Failure Risk Factors Kidney Disease 111

DAIC

SEPTEMBER 19, 2024

tim.hodson Thu, 09/19/2024 - 09:42 Sept. 18, 2024 – Astellas Pharma Inc. recently announced that Digitiva, a non-invasive digital health solution for heart failure management, has been listed with the U.S. a smartphone app designed for heart failure patients and built on the Welldoc, Inc.

Heart Failure 105

Heart Failure Technology Biomarkers Innovation 105

DAIC

FEBRUARY 26, 2024

milla1cf Mon, 02/26/2024 - 12:40 February 26, 2024 — More than 6 million Americans live with heart failure , and about half have an enlarged left ventricle, which causes stress on the heart and less blood pumped with each heartbeat. Boudoulas performed the first procedure on Jan.

Heart Failure 119

Heart Failure Open-Heart Surgery Hospital Outcomes 119

DAIC

APRIL 18, 2024

Getty Images milla1cf Thu, 04/18/2024 - 13:20 April 18, 2024 — Bayer AG and Asklepios BioPharmaceutical , Inc., Inhibiting the function of this protein, which is linked to congestive heart failure (CHF), could potentially lead to a therapeutic effect on the heart.1,2 Circ Heart Fail. Accessed April 2024. [4]

Heart Failure 105

Heart Failure Public Health Cardiac Function Research 105

DAIC

JULY 25, 2024

mtaschetta-millane Thu, 07/25/2024 - 09:08 July 25, 2024 — BioCardia, Inc. , FDA granted CardiAMP Cell Therapy a Breakthrough Device Designation for the treatment of ischemic heart failure.

Heart Failure 111

Heart Failure Quality of Life CMS Reimbursement 111

Frontiers in Cardiovascular Medicine

JANUARY 13, 2025

ObjectiveThis network meta-analysis was to compare the efficacy of different drugs on cardiac function, renal function, and clinical outcomes in patients with acute heart failure (AHF) accompanied by renal dysfunction.MethodsPubMed, EMBASE, Cochrane Library, and Web of Science were searched to screen all clinical trials of AHF between January 1st 2001 (..)

Heart Failure 52

Heart Failure Cardiac Function Outcomes 52

DAIC

JULY 31, 2024

mtaschetta-millane Wed, 07/31/2024 - 06:00 July 31, 2024 — A novel study co-authored by a heart failure cardiologist at University Hospitals Harrington Heart & Vascular Institute, demonstrates the effectiveness of a newly developed scoring system in identifying patients with Heart Failure with Preserved Ejection Fraction (HFpEF).

Heart Failure 111

Heart Failure Preserved Ejection Fraction Research Hospital 111

European Journal of Heart Failure

MARCH 10, 2025

Association of clonal haematopoiesis with heart failure incidence and outcomes: A systematic review and meta-analysis. Clonal haematopoiesis and heart failure: a meta-analysis. CH, clonal haematopoiesis; CI, confidence interval; HF, heart failure.

Heart Failure 40

Heart Failure Outcomes Coronary Artery Disease Risk Factors 40

DAIC

JANUARY 22, 2024

Getty Images milla1cf Mon, 01/22/2024 - 14:53 January 22, 2024 — Asklepios BioPharmaceutical , Inc. GenePHIT will include between 90 and 150 adults with left ventricle ejection fraction between 15 and 35%, who continue to suffer from heart failure symptoms despite guideline recommended therapy. Accessed January 2024.

Heart Failure 105

Heart Failure Public Health Cardiomyopathy 105

DAIC

MARCH 13, 2024

Getty Images milla1cf Wed, 03/13/2024 - 16:49 March 13, 2024 — BioCardia, Inc. , Getty Images milla1cf Wed, 03/13/2024 - 16:49 March 13, 2024 — BioCardia, Inc. , The CardiAMP Heart Failure II Trial is FDA approved to enroll up to 250 patients at up to 40 clinical centers. said Peter Altman , PhD.,

CMS 111

CMS Heart Failure Reimbursement Quality of Life 111

DAIC

MAY 28, 2024

milla1cf Tue, 05/28/2024 - 07:00 May 28, 2024 — Yoga focused on breathing, meditation, and relaxation is linked with symptom improvement in patients with heart failure, according to research presented at Heart Failure 2024 , a scientific congress of the European Society of Cardiology (ESC).

Heart Failure 98

Heart Failure Quality of Life Research Blood Pressure 98

DAIC

JUNE 21, 2024

milla1cf Fri, 06/21/2024 - 20:15 June 21, 2024 — Lexicon Pharmaceuticals, Inc. Our results demonstrated that in people with diabetes and recent worsening heart failure, sotagliflozin is cost-effective at commonly accepted willingness-to-pay thresholds,” said William S. healthcare system.

Heart Failure 105

Heart Failure Preserved Ejection Fraction Diabetes Research 105

DAIC

MARCH 7, 2024

Results showed reductions in heart death equivalents and MACCE, with a magnified reduction among patients with elevated NTproBNP, a common marker of heart distress. These patients saw more than a 17% lower rate of heart death equivalents at up to two years compared to control patients treated with heart failure medication alone (2.9%

Heart Failure 105

Heart Failure Biomarkers Reimbursement CMS 105

Nature Reviews - Cardiology

MARCH 25, 2024

Nature Reviews Cardiology, Published online: 26 March 2024; doi:10.1038/s41569-024-00997-0 In this Review, Bozkurt provides an overview of the management of patients with heart failure across the full range of left ventricular ejection fraction, derived from the recommendations in the latest US and European guidelines.

Heart Failure 98

Heart Failure Pharmacology 98

DAIC

MARCH 1, 2024

Getty Images milla1cf Fri, 03/01/2024 - 08:32 March 1, 2024 — Prenatal stress is a potential risk factor for cardiovascular disease in offspring later in life. Heart failure is a condition in which the heart cannot pump enough oxygen-rich blood to the organs, causing a variety of symptoms.

Heart Failure 105

Heart Failure Public Health Cardiovascular Disease Research 105

DAIC

APRIL 3, 2024

milla1cf Wed, 04/03/2024 - 18:55 April 3, 2024 — - Eko Health , a pioneer in applying artificial intelligence ( AI ) for early detection of heart and lung diseases, announces FDA clearance for its Low EF detection AI. Heart failure. For the first time, U.S. In the U.S., In the U.S., sensitivity, and 79.4%

Heart Failure 111

Heart Failure Cardiomyopathy AFIB Hospital 111

DAIC

FEBRUARY 6, 2024

Matthew Segar co-authored a study in JACC Heart Failure led by his research and residency mentor, University of Texas Southwestern Medical Center's Dr. Ambarish Pandey , that utilized a machine learning-based-approach to identify, understand, and predict diuretic responsiveness in patients with acute decompensated heart failure (ADHF).

Heart Failure 111

Heart Failure Research Hospital Cardiovascular Disease 111

Journal of Cardiovascular Electrophysiology

MARCH 10, 2025

ABSTRACT This state-of-the-art review is based on the Philippe Coumel Lecture in 2024 (Figure 1). It highlights the confluence of two major cardiovascular epidemics, atrial fibrillation and heart failure, with preserved ejection fraction.

Preserved Ejection Fraction 40

Preserved Ejection Fraction Atrial Fibrillation Heart Failure Pharmacology 40

Nature Reviews - Cardiology

JANUARY 25, 2024

Nature Reviews Cardiology, Published online: 26 January 2024; doi:10.1038/s41569-023-00986-9 In this Review, Varga and colleagues provide an overview of the evidence on immune checkpoint inhibitor-induced heart failure and cardiac dysfunction that is unrelated to myocarditis, and discuss how pharmacological targeting of immune checkpoints might be (..)

Heart Failure 90

Heart Failure Physiology Pharmacology 90

DAIC

OCTOBER 2, 2024

tim.hodson Wed, 10/02/2024 - 11:54 Heart failure is a rapidly growing public health issue that can be difficult to manage on a global scale. Researchers say these findings highlight the significance of heart failure as a global health issue. “To

Heart Failure 95

Heart Failure Public Health Research Cardiomyopathy 95

Cardiology Update

APRIL 15, 2024

Chadi Alraies discusses the top impactful trials presented at the 2024 American College of Cardiology conference. Learn more about the highlights from ACC 2024. The post ACC 2024 Highlights appeared first on Cardiology Update.

Research 98

Research Heart Failure Interventional Cardiology General Cardiology 98

DAIC

MAY 6, 2024

Getty Images milla1cf Mon, 05/06/2024 - 10:48 May 6, 2024 — Tenax Therapeutics, Inc. , Getty Images milla1cf Mon, 05/06/2024 - 10:48 May 6, 2024 — Tenax Therapeutics, Inc. , Expanding our intellectual property estate for levosimendan is a strategic priority for Tenax.

Preserved Ejection Fraction 105

Preserved Ejection Fraction Heart Failure Pulmonary Hypertension 105

DAIC

FEBRUARY 22, 2024

The inherited heart condition often goes undiagnosed until it advances to heart failure, which is why it’s important to identify those at risk and begin treatment early. heart failure/heart transplant programs that contributed to the study. Eventually heart failure may develop, which is late-phase disease.

Heart Failure 104

Heart Failure Sudden Cardiac Death Heart Transplant Cardiomyopathy 104

DAIC

FEBRUARY 12, 2024

Barostim is the world’s first FDA-approved neuromodulation heart failure device, which works by stimulating baroreceptors — natural sensors located in the wall of the carotid artery, according to CVRx. The therapy is designed to restore balance to the autonomic nervous system and thereby reduce the symptoms of heart failure.

Heart Failure 104

Heart Failure Hospital Quality of Life Heart attacks 104

HCPLive

JANUARY 2, 2025

Other recent research presented at ACR 2024 found increased CVD risk with glucocorticosteroid use.

Heart Failure 111

Heart Failure Research 111

Nature Reviews - Cardiology

FEBRUARY 6, 2024

Nature Reviews Cardiology, Published online: 07 February 2024; doi:10.1038/s41569-024-00988-1 In this Review, Lakhal-Littleton and Cleland use the latest understanding of iron homeostasis to evaluate existing and emerging markers of iron status, describe the reciprocal relationship between iron status and heart failure, and mechanistically examine (..)

Heart Failure 80

Heart Failure 80

Frontiers in Cardiovascular Medicine

MARCH 16, 2025

The patients were divided into an experimental group (HF patients) and a normal control group. Additionally, 211 patients from the Qiantang and Xixi centers formed an independent external validation cohort.

Heart Failure 52

Heart Failure Quality of Life Risk Factors Cardiovascular Disease 52

Medical Xpress - Cardiology

JULY 24, 2024

Increasing ketone supply to the heart in mice with heart failure with preserved ejection fraction (HFpEF) allowed their hearts to utilize more ketones and produce more energy, according to preliminary research presented today at the American Heart Association's Basic Cardiovascular Sciences Scientific Sessions 2024.

Preserved Ejection Fraction 75

Preserved Ejection Fraction Heart Failure Innovation Research 75

DAIC

FEBRUARY 15, 2024

(AskBio), a subsidiary of Bayer AG, have announced that the first patient has been randomized in GenePHIT (Gene PHosphatase Inhibition Therapy), a Phase II trial of AB-1002, also known as NAN-101, for the treatment of congestive heart failure (CHF). It is estimated that 26 million worldwide are living with congestive heart failure.

Heart Failure 89

Heart Failure Cardiomyopathy Quality of Life Innovation 89

Circulation

NOVEMBER 11, 2024

Circulation, Volume 150, Issue Suppl_1 , Page A4120990-A4120990, November 12, 2024. Background:Recent advancements have seen deep learning models help differentiate echocardiography images of patients with heart failure with preserved ejection fraction (HFpEF) from normal controls.

Heart Failure 75

Heart Failure Preserved Ejection Fraction Circulation 75

DAIC

FEBRUARY 21, 2024

Henry Ford Health's Center for Structural Heart Disease team delivered its first in Michigan FDA-approved VOQUE Transcatheter Tricuspid Valve Replacement System to a heart failure patient on February 13, 2024 at Henry Ford Hospital in Detroit. Other symptoms include swelling in the abdomen, legs or neck veins.

Heart Failure 105

Heart Failure Open-Heart Surgery Tricuspid Heart Disease 105

DAIC

FEBRUARY 22, 2024

Photo courtesy of Wake Forest University School of Medicine milla1cf Thu, 02/22/2024 - 13:51 February 22, 2024 — Wake Forest University School of Medicine , the academic core of Advocate Health , is expanding another research study to Advocate Christ Medical Center , in Oak Lawn, Illinois, just outside Chicago.

Heart Failure 105

Heart Failure Research Preserved Ejection Fraction Hospital 105